• Company Type For Profit
Eve Pharma is a preclinical drug delivery firm that is working to develop medications for the treatment of bacterial vaginosis. The firm focuses in gynecology and provides a product that promises to identify the source of a vaginal infection, allowing clinicians to easily diagnose and treat their patients.

Lists Featuring This Company

Startups Founded in 2016 That Failed
1,631 Number of Organizations • $3.6B Total Funding Amount • 2,447 Number of Investors
Closed Asia Companies (Top 10K)
9,673 Number of Organizations • $75.1B Total Funding Amount • 8,328 Number of Investors
Closed Tel Aviv Companies
1,087 Number of Organizations • $2B Total Funding Amount • 752 Number of Investors
Closed Life Science Companies
473 Number of Organizations • $6.6B Total Funding Amount • 724 Number of Investors

Frequently Asked Questions

Where is Eve Pharma's headquarters? Eve Pharma is located in Or Yehuda, Tel Aviv, Israel.Who invested in Eve Pharma? Eve Pharma is funded by Peregrine Ventures.How much funding has Eve Pharma raised to date? Eve Pharma has raised .When was the last funding round for Eve Pharma? Eve Pharma closed its last funding round on Aug 21, 2016 from a Seed round.Who are Eve Pharma's competitors? Alternatives and possible competitors to Eve Pharma may include METiS Therapeutics and Renovacor.